Skip to Content
Stock Analyst Update

Anheuser-Busch Does Well in Q2 Despite Headwinds

After a respectable second quarter, we maintain our wide economic moat rating fair value estimate for the firm.

Mentioned:

With much upside remaining to our valuation, it is too early to raise a toast to Anheuser-Busch InBev's (BUD) deleveraging, but the firm's execution in the second quarter was respectable. Against the backdrop of the obliteration of its on-premises business for several weeks, the firm beat our estimates on volume and margins and lowered its net debt balance. We view this a reminder to the AB InBev bears that despite the multiple headwinds facing the company, this is a well-managed and competitively advantaged business that should deliver strong cash flow generation for many years to come. We retain our wide economic moat rating and $96 fair value estimate. 

Second-quarter volume fell 17%, which was better than our estimate of a near 21% decline. By region there were some quite wide variances, with upside to our estimate in North America, where volume fell just 5.5% and the sell-through to retailers was flat. There was also downside to our estimate in the Middle Americas region, however, where volume fell over 36%. The strong performance in North America mirrors the respectable numbers just reported by Molson Coors, indicating that industry volume was more robust than we had expected. It seems likely that this was due to a substantial shift to the off-trade during the lockdown and to consumers returning in significant scale to on-premises locations when lockdown measures were lifted. Risk remains in North America, however, given that some states have reinstated social distancing measures in recent weeks. We anticipate a 2% regional volume decline in the second half of the year, with a strong 5% rebound next year.

Markets in the Middle Americas region have been hit very hard by the closure of the on-trade. Volume in Mexico and Colombia declined 38% and 31%, respectively, in the second quarter, and while pricing was positive, negative mix more than offset this and contributed to a greater decline in regional revenue than we had expected.

Morningstar Premium Members gain exclusive access to our full analyst reports, including fair value estimates, bull and bear breakdowns, and risk analyses. Not a Premium Member? Get this and other reports immediately when you try Morningstar Premium free for 14 days.

Philip Gorham does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

  • Verify your identity, personalize the content you receive, or create and administer your account.
  • Provide specific products and services to you, such as portfolio management or data aggregation.
  • Develop and improve features of our offerings.
  • Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.